{"id":576234,"date":"2022-06-24T00:00:00","date_gmt":"2022-06-24T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acrecg0037-2022-biopharma-major-depressive-disorder-dsm-v-access-reimbursement-access-reimbursement-digital\/"},"modified":"2026-04-30T11:20:09","modified_gmt":"2026-04-30T11:20:09","slug":"acrecg0037-2022-biopharma-major-depressive-disorder-dsm-v-access-reimbursement-access-reimbursement-digital","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acrecg0037-2022-biopharma-major-depressive-disorder-dsm-v-access-reimbursement-access-reimbursement-digital\/","title":{"rendered":"Major Depressive Disorder (DSM-V) – Access & Reimbursement – Access & Reimbursement – Digital Therapeutics in Mental Health (US)"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-576234","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-major-depressive-disorder","biopharma-therapy-areas-psychiatry","biopharma-geography-us","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576234\/revisions"}],"predecessor-version":[{"id":577546,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576234\/revisions\/577546"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=576234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}